DE60002143D1 - Behandlung autoimmunerkrankungen in säugern - Google Patents
Behandlung autoimmunerkrankungen in säugernInfo
- Publication number
- DE60002143D1 DE60002143D1 DE60002143T DE60002143T DE60002143D1 DE 60002143 D1 DE60002143 D1 DE 60002143D1 DE 60002143 T DE60002143 T DE 60002143T DE 60002143 T DE60002143 T DE 60002143T DE 60002143 D1 DE60002143 D1 DE 60002143D1
- Authority
- DE
- Germany
- Prior art keywords
- mammals
- treatment
- autoimmune diseases
- interleukin
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 208000023275 Autoimmune disease Diseases 0.000 title abstract 2
- 241000124008 Mammalia Species 0.000 title abstract 2
- 206010014824 Endotoxic shock Diseases 0.000 abstract 1
- 102000004388 Interleukin-4 Human genes 0.000 abstract 1
- 108090000978 Interleukin-4 Proteins 0.000 abstract 1
- 102000004889 Interleukin-6 Human genes 0.000 abstract 1
- 108090001005 Interleukin-6 Proteins 0.000 abstract 1
- 206010040070 Septic Shock Diseases 0.000 abstract 1
- 102000055135 Vasoactive Intestinal Peptide Human genes 0.000 abstract 1
- 108010003205 Vasoactive Intestinal Peptide Proteins 0.000 abstract 1
- 239000012190 activator Substances 0.000 abstract 1
- 108060000200 adenylate cyclase Proteins 0.000 abstract 1
- 102000030621 adenylate cyclase Human genes 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 229940028885 interleukin-4 Drugs 0.000 abstract 1
- 229940100601 interleukin-6 Drugs 0.000 abstract 1
- VBUWHHLIZKOSMS-RIWXPGAOSA-N invicorp Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)C(C)C)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 VBUWHHLIZKOSMS-RIWXPGAOSA-N 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 230000001173 tumoral effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES9901235A ES2160495B1 (es) | 1998-04-17 | 1999-06-04 | Uso de los peptidos vip y pacap para el tratamiento de enfermedades inflamatorias y autoinmunes en mamiferos. |
| ES9901235 | 1999-06-04 | ||
| PCT/ES2000/000197 WO2000074708A1 (es) | 1999-06-04 | 2000-06-02 | Metodo para el tratamiento del shock entotoxico y enfermedades inflamatorias y autoinmunes en mamiferos |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60002143D1 true DE60002143D1 (de) | 2003-05-22 |
| DE60002143T2 DE60002143T2 (de) | 2004-03-18 |
Family
ID=8308713
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60002143T Expired - Fee Related DE60002143T2 (de) | 1999-06-04 | 2000-06-02 | Behandlung autoimmunerkrankungen in säugern |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP1103270B1 (de) |
| AT (1) | ATE237347T1 (de) |
| AU (1) | AU4927700A (de) |
| CA (1) | CA2345030A1 (de) |
| DE (1) | DE60002143T2 (de) |
| PT (1) | PT1103270E (de) |
| WO (1) | WO2000074708A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE502004009530D1 (de) | 2003-07-14 | 2009-07-09 | Mondobiotech Ag | Substanzen mit biologischer aktivität des vasoaktiven intestinalen peptids für die behandlung von interstitiellen lungenerkrankungen |
| DE602005013922D1 (de) | 2004-02-24 | 2009-05-28 | Japan Tobacco Inc | Kondensierte heterotetracyclische verbindungen und deren verwendung als hcv-polymerase-inhibitor |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2138561B1 (es) * | 1998-04-17 | 2000-07-01 | Univ Madrid Complutense | Uso de los peptidos vip y pacap en el tratamiento del shock endotoxico en mamiferos. |
-
2000
- 2000-06-02 EP EP00931296A patent/EP1103270B1/de not_active Expired - Lifetime
- 2000-06-02 DE DE60002143T patent/DE60002143T2/de not_active Expired - Fee Related
- 2000-06-02 PT PT00931296T patent/PT1103270E/pt unknown
- 2000-06-02 CA CA002345030A patent/CA2345030A1/en not_active Abandoned
- 2000-06-02 AT AT00931296T patent/ATE237347T1/de not_active IP Right Cessation
- 2000-06-02 AU AU49277/00A patent/AU4927700A/en not_active Abandoned
- 2000-06-02 WO PCT/ES2000/000197 patent/WO2000074708A1/es not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE60002143T2 (de) | 2004-03-18 |
| PT1103270E (pt) | 2003-08-29 |
| CA2345030A1 (en) | 2000-12-14 |
| EP1103270B1 (de) | 2003-04-16 |
| WO2000074708A1 (es) | 2000-12-14 |
| ATE237347T1 (de) | 2003-05-15 |
| AU4927700A (en) | 2000-12-28 |
| EP1103270A1 (de) | 2001-05-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267381A (en) | A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders | |
| PT804252E (pt) | Agentes queladores metalicos que contem monoaminas diamidas e tiois | |
| EA200100872A1 (ru) | Композиция валдекоксиба | |
| CY1108610T1 (el) | Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες | |
| DK0682664T3 (da) | Forbindelser med både potent calciumantagonist og antioxiderende aktivitet og anvendelse deraf som cytobeskyttende midler | |
| UA42747C2 (uk) | Похідні пептиду,фармацевтична композиція та спосіб стимулювання секреції гормону росту | |
| CY2607B2 (en) | Synergistic combination of pde inhibitors and adenylate cyclase agonists or guanylcyclyse agonists | |
| DE69719798D1 (de) | Periphäre verabreichung von glp-1 analogen und derivate zur reguleirung der fettleibigkeit | |
| EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
| EA200000723A1 (ru) | Производные 2-(пурин-9-ил)-тетрагидрофуран-3,4-диола | |
| DE60219887D1 (de) | N-(3,-Dimethylindolin-6-yl)ä2-ä(4-pyridylmethyl)aminoü(3-pyridyl)ücarbonsäureamid und dieses enthaltende pharmazeutische Zubereitungen. | |
| WO2000008015A3 (en) | Fsh mimetics for the treatment of infertility | |
| EA200200208A1 (ru) | Синергитическая композиция | |
| EA200000911A1 (ru) | Новые кристаллические формы антивирусного соединения бензимидазола | |
| DK1039912T3 (da) | Angiostatiske midler og præparater til behandling af GLC1A-glaukom | |
| SV2002000235A (es) | Composiciones farmaceuticas que comprenden valdecoxib | |
| DK1032556T3 (da) | Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder | |
| DE69113221D1 (en) | Antiatherosclerotische und antithrombotische 2-amino-6-phenyl-4h-pyran-4-one. | |
| DE60129829D1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
| WO2000078795A3 (en) | Rufomycins and derivatives thereof useful as inhibitors of multi-drug resistance associated protein-1 (mrp-1) | |
| ATE237347T1 (de) | Behandlung autoimmunerkrankungen in säugern | |
| NO961423D0 (no) | Oligopeptider avledet fra C-reaktive proteinfragmenter | |
| ATE482217T1 (de) | Dithiolopyrrolon-derivate zur behandlung von proliferativen störungen | |
| BR0013665A (pt) | Uso de uma proteìna histacalina, composição farmacêutica, e, método de tratar ou impedir conjuntivite | |
| PT1207899E (pt) | Tratamento da rinite alergica com certas proteinas de ligacao de aminas vasoactivas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8332 | No legal effect for de | ||
| 8370 | Indication related to discontinuation of the patent is to be deleted | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |